AstraZeneca Pharma Shares Surge 12% After Approval to Launch Cancer Drug in India – Equitypandit
September 24, 2024September 24, 2024 Shares of AstraZeneca Pharma India Ltd. rallied 12%, reaching a day’s high of Rs 7,598 on 24th September, after the company announced that it had received approval from the Central Drugs Standard Control Organisation (CDSCO) to import and distribute durvalumab (Imfinzi) for an additional…